Ancora Pharmaceuticals
Medford
About Ancora Pharmaceuticals
Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in the United States. Its products include vaccines against bacterial, parasitic, and viral infectious diseases, as well as therapeutics to treat cardiovascular and metabolic diseases. The company was incorporated in 2001 and is based in Medford, Massachusetts. As of October 31, 2013, Ancora Pharmaceuticals, Inc. operates as a subsidiary of Corden Pharma Switzerland LLC.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $800.0K
- Funding stage: M&A
- Last round: Series Unknown (Nov 2009)
- Website: ancorapharma.com
- Phone: 7813053350
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/ancora-pharmaceuticals-739069 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.